We are live on ! Find out more
KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
FCMI
1
Foresite Capital Management IV
California
$109M
RCM
2
RA Capital Management
Massachusetts
$48M +$7.39M +671,092 +19%
O
3
OrbiMed
New York
$45.5M +$2.15M +195,700 +5%
NI
4
Nextech Invest
Switzerland
$33.9M
VVA
5
Vida Ventures Advisors
Massachusetts
$30.9M
BlackRock
6
BlackRock
New York
$23.1M +$90.1K +8,189 +0.4%
BC
7
Boxer Capital
California
$20.8M
Viking Global Investors
8
Viking Global Investors
Connecticut
$20.5M
Vanguard Group
9
Vanguard Group
Pennsylvania
$16.4M -$5.14M -466,789 -24%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$16.3M -$7.14M -648,219 -31%
Citadel Advisors
11
Citadel Advisors
Florida
$12.8M +$125K +11,350 +1%
DM
12
Deerfield Management
New York
$11.1M
FCMV
13
Foresite Capital Management V
California
$9.85M
LCM
14
Lynx1 Capital Management
Puerto Rico
$7.8M +$7.62M +692,508 New
NHAS
15
Novo Holdings A/S
Denmark
$7.03M +$783K +71,108 +13%
HMC
16
Harvard Management Company
Massachusetts
$5.61M
State Street
17
State Street
Massachusetts
$4.76M +$377K +34,224 +9%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$4.11M +$16.2K +1,471 +0.4%
RSCM
19
Rock Springs Capital Management
Maryland
$3.88M +$47.3K +4,300 +1%
American Century Companies
20
American Century Companies
Missouri
$3.6M +$1.17M +105,882 +50%
Federated Hermes
21
Federated Hermes
Pennsylvania
$3.47M
FCOMV
22
Foresite Capital Opportunity Management V
California
$3.28M
WP
23
Woodline Partners
California
$2.93M
Northern Trust
24
Northern Trust
Illinois
$2.34M -$62.7K -5,700 -3%
EC
25
EcoR1 Capital
California
$1.97M